Effects of Pioglitazone and Metformin Combination Therapy on High-Molecular-Weight Adiponectin Compared With Metformin Monotherapy in Type 2 Diabetes Mellitus Patients

被引：0
|
作者：
Matsushita, Takaya
Kaji, Akino
Kaji, Kuniaki
Takahashi, Eri
Usui, Takahiro
Asahi, Nobuteru
Sato, Tomoya
Ohono, Atushi
Ueki, Akio
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2490-PO
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [1] Effects of Pioglitazone and Metformin Fixed-Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes
    Perez, Alfonso
    Jacks, Randal
    Arora, Vipin
    Spanheimer, Robert
    JOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (12): : 973 - 982
  • [2] Combination therapy with pioglitazone and metformin in patients with type 2 diabetes
    Egan, J
    Rubin, C
    Mathisen, A
    DIABETES, 1999, 48 : A117 - A117
  • [3] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [4] Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    Comaschi, M.
    Demlcheli, A.
    Di Pietro, C.
    Bellatreccia, A.
    Mariz, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (04) : 387 - 398
  • [5] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    DIABETOLOGIA, 2002, 45 : A251 - A252
  • [6] Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus
    Sharma, Pramod Kumar
    Bhansali, Anil
    Sialy, Ravinder
    Malhotra, Samir
    Pandhi, Promila
    CLINICAL ENDOCRINOLOGY, 2006, 65 (06) : 722 - 728
  • [7] Body weight and BMI on Therapy with Pioglitazone in Combination with Metformin and/or sulphonylureas in Diabetes mellitus Type 2.
    Satler, Miriam
    Nirnberger, Guenther
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S25 - S25
  • [8] Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metformin
    Blevins, Thomas
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 789 - 793
  • [9] Alogliptin plus metformin combination therapy vs alogliptin or metformin monotherapy for type 2 diabetes mellitus
    Pratley, R.
    Wilson, C.
    Fleck, P.
    DIABETOLOGIA, 2012, 55 : S347 - S348
  • [10] The efficacy and safety of pioglitazone (Actos (TM)) As monotherapy and in combination with glibenclamide or metformin in patients with type 2 diabetes mellitus
    Shestakova, M. V.
    Balabolkin, M. I.
    Antsiferov, M. B.
    Mayorov, A. Y.
    Chugunova, L. A.
    Shamkhalova, M. S.
    Brevnova, N. N.
    Naumenkova, I. V.
    Zaytseva, N. V.
    Tsibina, L. V.
    Dedov, I. I.
    DIABETES MELLITUS, 2005, 8 (01): : 50 - 57
12345